Skip to main content
. Author manuscript; available in PMC: 2006 Feb 14.
Published in final edited form as: Nat Med. 2004 Jul 25;10(8):828–834. doi: 10.1038/nm1085

Figure 1.

Figure 1

Muscle transduction (blue) following systemic rAAV6 administration. (a–e) Mice were examined at 11 (a–c) or 14 (d,e) days after administration of 2 × 1011 (a,b), 1 × 1012 (c, d) or 1 × 1013 (e) vector genomes of rAAV6–CMV–lacZ (a–c) or rAAV6–CK6–lacZ (d,e) alone (a) or with 10 μg VEGF (b–e).